Instagram story viewer> @particlexcelerator> Posts

particlexcelerator

@particlexcelerator

undefined

POSTS STORIES REELS TAGGED

Download All

Sony didn’t just build a microsurgery robot — they spun it out into its own company with $11.6M in Series A funding. When Sony puts $11.6M behind a spinout, the technology behind it cleared a very high bar.

@sony built this for blood vessels under 1mm wide. Pen-like controllers filter out hand tremors. A 4K OLED camera gives surgeons a magnified, real-time view. Tools switch automatically mid-procedure — no pauses, no handoffs.

In 2024, medical staff with no specialized microsurgery training used it at Aichi Medical University to successfully connect animal blood vessels 0.6mm in diameter. That’s the world’s first time that kind of procedure has been done with a robot that auto-exchanges its own tools.

The tech spun out into #QolyCorporation — backed by @sony — and it’s heading toward commercialization. A skill that used to take years to master is now on its way to hospitals everywhere.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment ‘FREE MARKETING’ and we’ll send you a link to apply.

#HealthTech #MedTech #SurgicalRobotics #MedicalRobotics #SuperMicrosurgery #StartupHealth #DigitalHealth #HealthInnovation #MedicalTechnology #FutureOfSurgery #AIinHealthcare #HealthTechStartups #MedTechInnovation #StartupAccelerator #ParticleXcelerator taken in Los Angeles, California by @particlexcelerator

86

4

4 months ago

The immune system has a brake pedal. Three scientists just won the Nobel Prize for finding it.

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi were awarded the 2025 Nobel Prize in Physiology or Medicine for discovering regulatory T cells — the cells that keep the immune system from attacking the body’s own tissue. The gene that controls them is called FOXP3. When FOXP3 mutates, the brakes fail — and that failure is what drives conditions like Type 1 diabetes, MS, and rheumatoid arthritis.

There are now over 200 clinical trials running on therapies built from this research. The promise isn’t just better treatment — it’s precision. Instead of suppressing the entire immune system and hoping for the best, researchers can now learn to fine-tune it. Smarter cancer treatments. Better transplant outcomes. Immune therapy built on understanding the mechanism, not just managing symptoms.

Sakaguchi first described regulatory T cells in 1995. Brunkow and Ramsdell identified the FOXP3 mutation in 2001. The Nobel stage came in 2025. Thirty years of work that most people never heard of — until the science started saving lives.

The breakthrough was always there. What took three decades was building enough proof that the world couldn’t ignore it anymore.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment ‘FREE MARKETING’ and we’ll send you a link to apply.

#HealthTech #MedTech #Nobel2025 #ImmunologyResearch #RegulatoryTCells #FOXP3 #CancerResearch #AutoimmuneDisease #HealthcareInnovation #BiotechNews #MedicalBreakthrough #StartupHealth by @particlexcelerator

78

2

4 months ago

She spent months in a lab purifying 22 milligrams of a radioactive isotope so that a team of international scientists could attempt to create something that had never existed before.

Clarice Phelps — nuclear chemist, Navy veteran, and the first Black woman involved in the discovery of a new element — helped make Tennessine, element 117, possible. Her three months of precision purification work at #OakRidgeNationalLaboratory produced the berkelium-249 that was shipped to Russia, fused with calcium-48, and briefly became the second-heaviest element ever created. It exists for less than a second before decaying. The work it took to produce it lasted years.

What Phelps talks about most isn’t the chemistry. It’s who gets to see themselves doing it. For the first 18 years of her career, she was the only Black woman in her field. She knows what that absence costs — and she knows what her visibility can change for the girls watching now.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment ‘FREE MARKETING’ and we’ll send you a link to apply.

#ClaricePhelps #HealthTech #WomenInSTEM #MedTech #NuclearChemistry #FounderStory #StartupMarketing #BlackWomenInSTEM #HealthInnovation #WomenInScience #StartupGrowth #ParticleXcelerator taken in Los Angeles, California by @particlexcelerator

104

5

4 months ago

He didn't know how to code. He failed accounting. He applied to Harvard ten times and got rejected every time. Jack Ma built Alibaba — one of the most valuable companies in history — and his hiring philosophy was simple: find people smarter than you in every single room, then make sure they can work together.

In his own words, the vision part is almost irrelevant if the team can't function. Smart people, he said, have a notoriously hard time working with each other. Don’t obsess over talent density and skip the culture that holds it together.

Getting the product right is only half the equation. The other half is building a room full of brilliant people who trust each other enough to move fast.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment 'FREE MARKETING' and we'll send you a link to apply.

#JackMa #Alibaba #FounderMindset #StartupCulture #HealthTech #MedTech #HealthAndWellness #StartupLeadership #GTMStrategy #ParticleXcelerator by @particlexcelerator

41

1

4 months ago

The current gold standard for autism diagnosis — the Autism Diagnostic Observation Schedule — requires rare specialist expertise, resists standardization across clinical settings, and is grounded almost entirely in subjective clinical observation. For a condition affecting 1 in 31 children in the U.S., that creates a structural bottleneck with real developmental consequences.

@blinklab.app's Dx1 changes the inputs. During a 15-minute smartphone session, a child watches age-appropriate video while the platform's AI reads facial reflexes, eye and eyelid movements, acoustic startle responses, postural stability, and vocal patterns — capturing objective, reflex-based neurometric biomarkers without a specialist in the room. In a peer-reviewed multi-center study of 536 children published in Autism Research this January, the approach reliably detected distinct sensorimotor profiles associated with autism across age, gender, and clinically diverse populations. In a separate real-world U.S. pilot study of 485 children — intentionally designed to reflect the full spectrum of developmental presentations seen in clinical practice — Dx1 hit 83.7% sensitivity and 84.7% specificity. Both figures clear the FDA's own minimum threshold for clearance by nearly 20 points.

The FDA trial is now live across 10 major U.S. hospitals. Morocco already launched a government-mandated national program built around Dx1, targeting approximately 600,000 children born annually. That's a sovereign government deploying a smartphone-based AI diagnostic tool at population scale — before FDA clearance.

The science is moving faster than the system. The question is how quickly access follows.
Follow Particle Xcelerator for more breakthroughs shaping the future of HealthTech and MedTech.

#AutismDiagnosis #MedTech #HealthTech #AIinHealthcare #DigitalHealth #AutismAwareness #PediatricHealth #HealthTechInnovation #AIdiagnostics #ParticleXcelerator #AutismResearch #MedicalAI #HealthInnovation #EarlyIntervention #NeurodevelopmentalHealth by @particlexcelerator

3

3

4 months ago

Medicine called it permanent. Dr. Tatiana Coelho de Sampaio (#TatianaCoelhoSampaio) spent 30 years disagreeing.

Working at @ufrj.oficial in Rio de Janeiro, she studied laminin — a protein found in the human placenta that most researchers had long moved past. Her lab developed polylaminin: a biological scaffold that, when injected into a spinal cord injury site, gives damaged neurons a physical path to reconnect.

Patients with complete spinal cord injuries showed voluntary motor contraction for the first time in documented medical history. On January 5, 2026, ANVISA authorized Phase 1 clinical trials.
No funding rounds. No headlines. Just conviction that the science was worth it — long before the world caught up.

Every founder building in health right now knows that feeling. That's exactly who Particle Xcelerator is built for.
Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment 'FREE MARKETING' and we'll send you a link to apply.

#HealthTech #MedTech #StartupFounder #HealthInnovation #Polylaminin #SpinalCordInjury #NeuralRegeneration #FounderStory #StartupLife #HealthTechStartup #GTMStrategy #StartupMarketing #ParticleXcelerator #Biotech #HealthcareInnovation by @particlexcelerator

3

2

4 months ago

94% of companies that suffer catastrophic data loss never recover. For a pre-raise startup, that may equal losing the proof of concept that gets you funded.

Today is World Backup Day. Let this be your reminder to run your operational audits.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue.

Comment ‘FREE MARKETING’ and we’ll send you a link to apply.

#HealthTech #MedTech #StartupFounder #GTMStrategy #InvestorReady #WorldBackupDay #ParticleXcelerator

FACEBOOK
94% of companies that suffer catastrophic data loss never recover. For a pre-raise startup, the real loss is the story that gets you funded.

Today is World Backup Day. Let this be your reminder to run your operational audits.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue.

Comment ‘FREE MARKETING’ and we’ll send you a link to apply.

#HealthTech #MedTech #StartupFounder #GTMStrategy #InvestorReady #WorldBackupDay #ParticleXcelerator by @particlexcelerator

3

2

4 months ago

Scientists just built a real-life T-1000 — and it works exactly like you'd expect.

Researchers from @snu.official (Seoul National University) and Gachon University published a new soft robot in Science Advances that squeezes through narrow gaps, reforms its shape on the other side, and can capture and carry foreign materials through its environment. The system uses a liquid core encased in hydrophobic particles that give it structural stability without sacrificing the fluidity underneath. Guide it with ultrasound, and it moves with precision while still adapting to complex spaces.

The researchers are already exploring biomedical applications — including targeted drug delivery and treatment pathways inside the human body.

This is the direction surgical robotics, search-and-rescue tech, and minimally invasive medicine are heading: systems that behave more like biology than machinery.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment 'FREE MARKETING' and we'll send you a link to apply.

#HealthTech #MedTech #SoftRobotics #Robotics #AIInHealthcare #MedicalRobotics #HealthTechInnovation #StartupHealth #DigitalHealth #FutureMedicine #BiomedicalEngineering #HealthcareInnovation #MedTechStartups #ScienceAdvances #ParticleXcelerator by @particlexcelerator

39

2

4 months ago

Around 80% of kids getting an MRI had to be sedated first. Not because it hurt — because the room terrified them.

GE Healthcare's Doug Dietz redesigned the experience around the machine. Pirate ships. Rocket ships. Nine adventure themes with storytelling scripts for the technicians. Sedation rates dropped to under 1%. Patient satisfaction went up ~90%.

The machine never changed. The experience did.
One girl came out of the pirate ship scanner and asked her mom if they could come back tomorrow.

The product was never the problem. The user experience was. That's the entire job of a great go-to-market strategy done right.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment 'FREE MARKETING' and we'll send you a link to apply.

#HealthTech #MedTech #HealthcareInnovation #PediatricCare #DesignThinking #StartupGrowth #GEHealthcare #AdventureSeries #PatientExperience #HealthTechStartup #MedTechStartup #FounderLife #HealthcareDesign #GTMStrategy #ParticleXcelerator taken in Los Angeles, California by @particlexcelerator

3

4

4 months ago

Robotic surgery is now precise enough to operate on structures smaller than a human hair.

The systems making this possible aren't just mechanically advanced — they're running continuous real-time feedback loops, reading sensor data and adjusting force and movement faster than any human hand could respond.

What this means practically: procedures that once carried high complication risk because of tremor, fatigue, or limited visibility are being redesigned around machine-level consistency. The surgeon directs. The robot executes without deviation.

We're not at the finish line — but the gap between lab demonstration and routine OR deployment is closing faster than most people in the space realize.

Follow @particlexcelerator for weekly HealthTech and MedTech intelligence.

#RoboticSurgery #HealthTech #MedTech #SurgicalRobotics #MedicalInnovation #HealthTechFounders #StartupHealth #AIinHealthcare #DigitalHealth #MedicalRobotics #FutureOfMedicine #HealthcareInnovation taken in Los Angeles, California by @particlexcelerator

27

4

4 months ago

The tools on #ThePitt aren't props — they're FDA-cleared and already in real ERs.
The LUCAS 3 by @StrykerEC automates chest compressions so paramedics can focus on everything else a code demands. WiFi-connected and remotely adjustable, it's been standard in emergency transport since FDA clearance in 2018.

The Butterfly iQ3 by @butterflynetwork is a pocket-sized ultrasound probe with built-in AI that guides each scan and interprets anatomy in real time. It won Best Medical Technology at the Prix Galien USA Awards in 2024 and is now in all 100 of the top U.S. health systems.

The show's AI charting storyline — where transcription software hallucinated patient history and confused specialties — reflected a real tension in clinical AI: powerful tools, genuine risks, and an industry still writing the guardrails.

VR for pain management is neuroscience. Immersive sensory input measurably reduces pain perception, and emergency departments are using headsets during procedures without additional medication.

XStat was built for battlefield trauma and FDA-cleared for civilian use in 2015. Expanding hemostatic sponges injected into a wound cavity stop an arterial bleed in about 20 seconds.

The gap between what's clinically possible and what's widely adopted is still wide — and that's exactly where the next wave of MedTech companies will be built.

Follow @particlexcelerator for the breakthroughs worth knowing about.

#ThePitt #MedTech #HealthTech #EmergencyMedicine #MedicalInnovation #HealthTechNews #ERTech #AIInHealthcare #PointOfCareUltrasound #StartupHealth #MedTechFounders #DigitalHealth #ClinicalInnovation #HealthcareAI #ParticleXcelerator taken in Los Angeles, California by @particlexcelerator

3

4

4 months ago

Most HealthTech founders don't fail because the product wasn't good enough. They fail because they went to market in the wrong order.

They build before they find customers. They perfect the product before they test the message. They pitch investors before they have traction. They hire for scale before they have repeatable sales. Each of those decisions feels logical in isolation — and each one compounds the problem.

Messaging isn't a launch deliverable. It's how you find out whether you're solving the right problem. That discovery needs to happen early — not after the build is done and the runway is shorter.

Two paying customers and a retention rate will outperform a polished deck every time. Traction talks louder than story.

The sequence that works: Message → Market → Traction → Scale. In that order.

Particle Xcelerator works with post-MVP HealthTech and Health & Wellness startups ready to prove demand and drive early revenue. Comment 'FREE MARKETING' and we'll send you a link to apply.

#HealthTech #MedTech #StartupGrowth #GTMStrategy #FounderAdvice #HealthTechStartup #GoToMarket #StartupMarketing #EarlyStage #TractionFirst #HealthcareInnovation #StartupFounder #MarketFit #ParticleXcelerator taken in Los Angeles, California by @particlexcelerator

3

4

4 months ago